. Polyploidy is thought to be an efficient method of increasing the content of the genome by avoiding the costly and slow process of cytokinesis [1, 3, 4] . Polyploidy can also affect gene regulation by amplifying a subset of genomic regions required for specific cellular function [1, 3, 4] . This mechanism is found in the fruit fly Drosophila melanogaster, where polyploid ovarian follicle cells amplify genomic regions containing chorion genes, which facilitate secretion of eggshell proteins [5] . Here, we report that genomic amplification also occurs in mammals at selective regions of the genome in parietal trophoblast giant cells (p-TGCs) of the mouse placenta. Using whole-genome sequencing (WGS) and digital droplet PCR (ddPCR) of mouse p-TGCs, we identified five amplified regions, each containing a gene family known to be involved in mammalian placentation: the prolactins (two clusters), serpins, cathepsins, and the natural killer (NK)/C-type lectin (CLEC) complex [6] [7] [8] [9] [10] [11] [12] . We report here the first description of amplification at selective genomic regions in mammals and present evidence that this is an important mode of genome regulation in placental TGCs.
While most cells maintain a diploid state, polyploid cells exist in many organisms and are particularly prevalent within the mammalian placenta [1] , where they can generate more than 900 copies of the genome [2] . Polyploidy is thought to be an efficient method of increasing the content of the genome by avoiding the costly and slow process of cytokinesis [1, 3, 4] . Polyploidy can also affect gene regulation by amplifying a subset of genomic regions required for specific cellular function [1, 3, 4] . This mechanism is found in the fruit fly Drosophila melanogaster, where polyploid ovarian follicle cells amplify genomic regions containing chorion genes, which facilitate secretion of eggshell proteins [5] . Here, we report that genomic amplification also occurs in mammals at selective regions of the genome in parietal trophoblast giant cells (p-TGCs) of the mouse placenta. Using whole-genome sequencing (WGS) and digital droplet PCR (ddPCR) of mouse p-TGCs, we identified five amplified regions, each containing a gene family known to be involved in mammalian placentation: the prolactins (two clusters), serpins, cathepsins, and the natural killer (NK)/C-type lectin (CLEC) complex [6] [7] [8] [9] [10] [11] [12] . We report here the first description of amplification at selective genomic regions in mammals and present evidence that this is an important mode of genome regulation in placental TGCs.
RESULTS AND DISCUSSION
We tested whether a subtype of trophoblast giant cells (TGCs), the parietal TGCs (p-TGCs) of the mural trophectoderm (Figure 1A) , amplify selective genomic regions. In the mouse, the embryonically derived trophectoderm gives rise to several subtypes of TGCs, all of which form polyploid nuclei via endoreplication [14] . p-TGCs, which are found at the border of the maternal-fetal interface ( Figure 1A ), have the largest degree of polyploidy [15] . By embryonic day 10.5 (E10.5), p-TGCs can generate more than 900 copies of the genome, with most nuclei between 30N and 900N [2] . In addition, the degree of polyploidy in p-TGCs is correlated with location. p-TGCs directly above the center of the placental disk (polar trophectoderm) have a lesser degree of polyploidy, and polyploidy increases the further away the TGCs are from this point (toward the mural trophectoderm) [16] . We have previously found underrepresented (UR) domains in the most polyploid p-TGCs, those of the mural trophectoderm [17] . Conversely, copy number variations (CNVs) were not reported in a mixture of p-TGCs collected from both the polar and mural trophectoderm [18] .
To determine whether p-TGCs of the mural trophectoderm amplify specific genomic regions, we examined paired-end whole-genome sequencing (WGS), at 103 coverage, on five individual E9.5 p-TGCs and their cognate embryos from three separate litters of C57BL/6 mice [17] . While we had previously identified only UR domains when examining this dataset in conjunction with our E9.5 array comparative genomic hybridization dataset (aCGH; FDR = 0.0001) [17] , we found that the more sensitive WGS data together with a less stringent cutoff criteria identified amplified regions ( Figures 1B and S1 ). To further investigate the amplified regions, we used the statistical program BIC-seq, which identifies CNVs by comparing a test and control genome and minimizes the Bayesian information criterion [13] . We found five reproducibly amplified regions, at a log10 p value < À250 for each (Figures 1B and S1; Table S1 ), four of which are located on chromosome 13. The regions are 521,249 to 1,671,849 bp long (mean/median of 932,199/ 759,599 bps), with 22%-37% amplification above the rest of the genome (mean/median of 26/22%) (Table S1 ). In previous work, we identified amplified regions at E11.5, E13.5, and E16.5 that were not reproducible between stages and between biological replicates [17] . Furthermore, these amplified regions contained no genes, suggesting that they are non-functional. There is no overlap between the five amplified regions reported here and these later, more stochastic events. It will be crucial to perform the more sensitive WGS on later stages to further investigate amplification dynamics.
We next analyzed the gene content of the five E9.5 amplified regions. We reasoned that the amplified regions may provide a functional advantage for successful placentation, similar to Drosophila follicle cells that amplify genes necessary for eggshell formation [5] . Consistent with our hypothesis, we found that the four amplified regions on chromosome 13 each contain a different placental gene family: the prolactins (two separate clusters), serpins, and cathepsins [10] [11] [12] (Figure 2A ; Table S1 ). In addition, the amplified region on chromosome 6 contains the natural killer (NK)/C-type lectin (CLEC) complex, which has been implicated in placental health [6, 7, 9] (Figure 2A ; Table S1 ).
All five of the amplified regions contain genes known to be important for placentation and pregnancy. The prolactins are hormones and cytokines crucial for pregnancy adaptations [12] . They are expressed by many organs, including several cell types in the placenta (TGCs, spongiotrophoblasts), the decidua, and the lactotroph cells in the pituitary gland, where they play roles in regulating vascular remodeling, hematopoiesis, progesterone production, pancreatic beta-cell proliferation, and mammary development [12, 19] . In particular, trophoblast cells secrete prolactins to promote hematopoiesis and vascular remodeling. In functional studies of mice with a null mutation for Prl4a1 (Prlpa), which is normally expressed by trophoblast cells, these mice are unable to adapt to physiological stressors, resulting in failure to maintain pregnancies [20] . The serpins are intracellular serine protease inhibitors that are synthesized in placental and immune tissues [10] . Mice heterozygous for a deletion containing both the serpin and the larger of the two amplified prolactin regions (the big prolactin cluster) are small or often die after E12.5 [21, 22] , phenotypes consistent with placental abnormalities [14, 23] . The cathepsin family consists of proteases and cathepsin pro-peptides (TPBPA, TPBPB, CTLA2A, CTLAB), all of which are expressed by placental cells [11] . The canonical function of the cathepsins is to facilitate placental invasion by degrading extracellular matrix proteins. In functional studies, mice that overexpress Cts7 have a thinner spongiotrophoblast layer mid-gestation and an associated proliferation defect [24] . Conversely, Cts8 overexpression leads to an enlarged giant cell/spongiotrophoblast layer and fetal lethality [24] . Finally, genes in the NK/CLEC complex consist of C-type lectin-like natural killer receptors and their C-type lectin-like glycoproteins ligands [6] . Human data suggest that the NK/CLEC complex is crucial for successful pregnancies [7, 9] . The most well-studied model of NK receptors and ligands in pregnancy is the human natural killer immunoglobulin-like receptors (KIRs) and their human leucocyte antigen (HLA) ligands [7] . During pregnancy, uterine NK cells express KIRs that interact with the HLA ligands expressed by extravillous trophoblast cells of the placenta. This interaction is thought to control both the depth of trophoblast invasion and the extent of vascular remodeling, as certain combinations of KIRs and the extremely polymorphic HLA-C locus are correlated with impaired trophoblast invasion and vascular remodeling. Although the role of these receptors and ligands in mice has been less well characterized, both mice and human genomes contain a homologous NK/CLEC complex, which plays a role in immune response [6, 9] . Intriguingly, the mouse NK/CLEC cluster is composed of a tight linkage of both the NK receptors and their CLEC ligands, which are thought to function similarly to the KIR/HLA pairings.
Because WGS analysis can be affected by genome assembly and mapping artifacts, we further validated the prolactin and serpin amplified regions by performing digital droplet PCR (ddPCR). ddPCR is an extremely quantitative form of PCR in which each PCR reaction is partitioned into up to 20,000 individual droplets and PCR amplification then occurs within each droplet, essentially repeating the same PCR experiment independently thousands of times [25] . After PCR completion, Poisson statistics are used to determine the copy number in the original sample [25] . To collect DNA for ddPCR, we dissected E9.5 p-TGCs and cognate embryos from pregnant C57BL/6 mice. We then performed ddPCR on three different E9.5 p-TGCs and cognate embryos for multiple genomic regions in the big prolactin and serpin amplified regions. As controls, we used regions that are underrepresented on chromosome 13 and chromosome 14 (UR domains) [17] . We also examined the Nrsn1 and Sox4 regions and the Foxf2 region, which flank the big prolactin and serpin clusters, respectively, but have equivalent genomic copies in p-TGCs and embryos [17] . Compared to embryos, we found that p-TGCs have significantly more copies of amplified regions (p < 0.05), significantly fewer copies of UR domains (p < 0.05), and similar copies of the regularly replicated regions that flank the amplified regions ( Figure 2B ). Together, our WGS and ddPCR data show that p-TGCs amplify specific regions of the genome. BIC-seq calls slightly different amplified boundaries in each sample analyzed, suggesting that amplification tapers near the edges of the clusters (Table S1) . Further supporting this model, we found that ddPCR on regions in the middle of the big prolactin and serpin clusters (Prl8a8 and Prl8a1, and Serb6b and Serb9d, respectively) have a more significant difference between p-TGCs and embryonic samples (p % 0.005), corresponding to a larger Arrowheads indicate amplified regions called by BIC-seq [13] in all five WGS samples with a log10 p value < À250. UR: UR domains, which are more prominent than the amplified regions. See Figure S1 for all autosomes and Table S1 for coordinates, percent amplification, and exact p values for amplified regions.
degree of amplification, than those near the edges of the clusters (Prl3b1, Prl8a6, and Prl5a1, and Serb6d, respectively; p < 0.05) ( Figure 2B ). In addition, although trending toward amplification, the very 3 0 end of the serpin cluster, Serb6a, was not significantly amplified via ddPCR ( Figure 2B ). Overall, we find a gradient of amplification, in which amplification decreases from the middle of the region to the margins.
To investigate whether the prolactin, serpin, and cathepsin families, as well as the NK/CLEC complex, are highly expressed in p-TGCs, we examined our RNA-seq datasets from isolated E9.5 p-TGCs [17] . First, we examined gene expression on chromosome 13, which contains four of the five amplified clusters. We found that 23 of the 100 most highly expressed genes on chromosome 13, out of 392 total annotated expressed genes, are genes contained within the four amplified regions (p < 0.0002; Figure 3A ; Table S2 ): three of these reside in the mini prolactin cluster, twelve are in the big prolactin cluster, six are in the serpin cluster, and two are in the cathepsin cluster. In addition, the big prolactin cluster contains the two most highly expressed genes on chromosome 13, Prl7a1 and Prl4a1 ( Figure 3A ; Table  S2 ). Moreover, Prl7a1 and Prl4a1 are the 1 st and 29 th most highly expressed genes in the entire p-TGC transcriptome. We next examined the NK/CLEC complex on chromosome 6. We did not find any of the killer cell lectin-like receptors expressed in our dataset, which is consistent with this type of receptor being expressed by NK cells, and not by trophoblast cells [7] . However, we did find expression of several of the CLEC ligands in our p-TGC dataset, including Clec1a as the 53 rd most highly expressed gene on chromosome 6, out of 535 annotated expressed genes. Together, these data suggest that although amplification leads to high gene expression, not all amplified genes are expressed. In particular, the receptors in the NK Table S1 for genes in table format. (B) ddPCR for the big prolactin and serpin amplified regions. Ratio of positive droplets, indicating copy level, in test versus control regions is shown for biological triplicates (each replicate consists of DNA from p-TGCs from one placenta and their cognate embryo); error bars indicate 95% confidence interval. Left: compared to embryos, p-TGCs have significantly fewer copies of UR domains (p < 0.05). Middle: p-TGCs have significantly more copies of amplified regions in the big prolactin loci (p < 0.05) and similar copy levels in the flanking regions (Nrsn1 and Sox4). In addition, the region in the middle of the loci (Prl8a8 and Prl8a1) has a more significant difference between p-TGC and embryonic samples (p % 0.005), corresponding to a larger degree of amplification, than those near the edges of the clusters (Prl3b1, Prl8a6, and Prl5a1; p < 0.05). Right: p-TGCs have significantly more copies of amplified regions in the middle of the serpin loci (p < 0.05) and similar copy levels in the flanking region (Foxf2). In addition, the region in the middle of the loci (Serb6b and Serb9d) has a more significant difference between p-TGC and embryonic samples (p % 0.005), corresponding to a larger degree of amplification, than those near the edges of the clusters (Serb6d; p < 0.05; and Serb6a, which, although trending toward amplification, was not significantly amplified). In the middle and right panels, bold red text with solid black bar beneath indicates genes in the amplified loci, whereas black text with dashed bar underneath indicates genes flanking the amplified loci.
complex, which are not expressed in p-TGCs, may be amplified as a byproduct of amplification of their CLEC ligands. This is similar to other systems with genomic amplification, as in both Drosophila follicle cells and in cancer, only a subset of amplified genes are highly expressed [26, 27] . Together, our expression data and published functional data suggest that the prolactins, serpins, cathepsins, and the NK/CLEC complex are involved in finely tuning trophoblast function. While amplification can be used to increase gene copy number and thus gene transcription, it may also be a mechanism to increase availability of regulatory elements, which are often shared when genes are closely clustered [28, 29] . Therefore, we examined ChIP-seq data for histone marks for enhancers (H3K4me1, H3K27ac) from cultured p-TGCs [17] . We found only one enhancer in the middle of the big prolactin cluster, suggesting that multiple genes share this regulatory element ( Figure 3B ). To further investigate this enhancer, we performed motif analysis to find transcription factor binding motifs. Using FIMO (Find Individual Motif Occurrences) [30] , for the transcription factors that were expressed in our p-TGC RNA-seq dataset, we found that there were multiple occurrences of binding sites for three transcription factors previously implicated in prolactin regulation [31] : Ap1 (13 sites), FoxJ2 (11 sites), and Gata3 (8 sites) (p < 0.0001 for motif occurrence). Next, we examined putative enhancer regions in the other amplified regions. We found multiple H3K4me3/H3K27Ac marks distributed throughout these regions, suggesting a diversity of enhancer usage ( Figures 3B,  3C , and S2). In addition, for the NK/CLEC complex, there is a concentration of putative enhancers around the CLEC genes, which are expressed in p-TGCs, but there are no putative enhancers around the NK genes, which are not expressed (Figure 3C) , further suggesting that the CLEC ligands specifically are important for p-TGC function. In the future, it will be interesting to tease apart the effect of amplifying either the regulatory or coding sequences, especially for the big prolactin cluster.
Next, we wanted to examine how amplified regions are synthesized in p-TGCs. In Drosophila, the entire genome of follicle cells undergoes endoreplication until stage 10A [32] . After this time, most of the genome stops synthesis, except for the chorionic gene clusters, which results in selective amplification of these loci. This can be visualized as distinct foci only in the amplified regions after bromodeoxyuridine treatment [32] . Therefore, we asked whether p-TGC amplified regions also undergo replication independently of the rest of the genome, similar to chorion gene amplification in Drosophila. To this end, we treated E9.5 pregnant female mice for 20 min with ethynyl deoxyuridine 
. Amplified Regions Are Enriched for Highly Expressed Genes and Associated Enhancers
(A) Expression levels of the 100 most highly expressed genes on chromosome 13. Amplified genes are in yellow. 23 of these highly expressed genes, including the top two, are in amplified regions (p < 0.0002). b-Prl, big prolactin cluster; m-Prl, mini-prolactin cluster; Serp, serpin cluster; Cath, cathepsin cluster. See Table S2 for a list of the 100 most highly expressed genes on chromosome 13. (B and C) Integrative Genomics Viewer screenshots of the amplified loci, showing location of putative enhancer elements (both H3K4Me1 and H3K27Ac enrichment). Red arrows and box indicate enhancers. (B) Whereas the big prolactin locus has one putative enhancer in the middle of the cluster (left, red box), the other loci, such as the mini prolactin locus (right), have many putative enhancers (red arrows). See (C) for the NK/CLEC complex and Figure S2 for the serpin and cathepsin amplified loci. Prolactin genes in red are in the 100 most highly expressed genes on chromosome 13 in p-TGCs. These genes are not in closer proximity to the big enhancer (red box) than the other genes in this cluster. (C) For the NK/CLEC complex, the putative enhancers are concentrated around the CLEC genes (in red), many of which are expressed in p-TGCs, but not around the NK genes, which are not expressed.
(EdU), which labels actively replicating DNA in S phase. p-TGCs of the mural trophectoderm were then visualized using confocal fluorescent microscopy. For each litter, we examined at least five fields of view, each containing 15-20 p-TGC nuclei. If the p-TGC amplified regions were synthesized independently from the rest of the genome, we would expect to observe five regions of EdU incorporation, corresponding to the regions of amplification. However, we never observed EdU incorporation outside of the characteristic patterns of either early or late S phase [33, 34] (Figure 4A) . The early S phase pattern consists of EdU incorporation into most of the p-TGC nucleus, except for heterochromatic foci, whereas the late S phase pattern consists of EdU labeling the heterochromatic foci and the heterochromatic DNA at the periphery of the nucleus. This suggests that the amplified regions in p-TGCs form while the rest of the genome is still undergoing endoreplication and that the mechanism for amplification in mammals is distinct from that in Drosophila.
We next investigated whether the amplified regions are controlled by replication timing. Previously, we demonstrated a strong correlation between the formation of underrepresented regions (UR domains) and a subset of late-replicating regions [17] . Therefore, we tested whether perturbing replication timing genetically using Rif1 À/À mice, which fail to maintain replication timing and die during mid-gestation [35, 36] , would affect the formation of amplified regions and/or UR domains. We collected p-TGCs and cognate embryos at E9.5 from Rif1 À/À and wild-type littermates and performed ddPCR for several amplified regions, UR domains, and regularly replicated regions. We found that, while copy number was restored to embryonic levels in UR domains in Rif1 À/À mice, amplified regions were present in both Rif1 À/À mice and control littermates ( Figure 4B ). These data suggest that although UR domains are highly dependent on replication timing, amplified regions are independent of this process.
We found that mouse p-TGCs both amplify and underrepresent specific genomic regions that have very different physical properties and mechanisms of formation. Whereas there are only five amplified regions, there are at least 47 UR domains [17] , and the amplified domains are less prominent than the UR domains in their degree of CNV (Figures 1B and S1 ; Table S1 ). The differences in amplification and underrepresentation could be explained by separate control mechanisms. This is supported by our data from the Rif1 À/À mice, where UR domain formation, but not amplification, is dependent on replication timing. While UR domains could co-opt existing late-replicating regions of the genome to become underrepresented, the excess firing of origins of replication at amplified sites may require more complicated changes to cellular machinery and DNA sequence. This is supported by data from Drosophila, where transgenic and deletion analyses have shown that localized genomic amplification is regulated by specific cis-regulatory elements. For example, the Drosophila amplified region 66D contains an amplification control element (ACE3), an ori-beta origin of replication, and at least four amplification-enhancing regions (AERs) [37] [38] [39] [40] . However, the cis-regulatory elements in the amplified loci have no consensus sequence, and therefore not only has a unifying mechanism for all of the amplified loci in Drosophila not yet been discovered, it will be difficult to determine whether a similar mechanism is used in mice without analogous functional experiments. Amplified regions and UR domains form in polyploid cells with averages of 30-900 copies of the genome [2] , which is important to consider when evaluating the degree and potential effect of CNV. All of the amplified regions and UR domain still maintain a greater-than-diploid karyotype given that UR domains are 28%-54% less than and amplified regions are 22%-37% more than the rest of the genome (i.e., 28%-54% of 30-900 copies). In addition, p-TGCs have a wide range of ploidy that changes depending on gestational age and location. For example, ploidy levels were shown to increase the further a p-TGC is located from the polar trophectoderm [16] . Thus, what we classify as p-TGCs are most likely a heterogeneous population of cells with a wide range of ploidy, suggesting that some of these could have much larger degrees of CNVs, and therefore we detect only the average of this mixture. An intriguing related idea is that p-TGCs, or even other TGC subtypes, could have different regions of amplification corresponding to specialized cellular function. Single-cell WGS will be needed to resolve this in the future. Regardless, in Drosophila, even low levels of genomic amplification have been shown genetically to be critical for development [41] , implying that CNVs can be subtle but highly impactful.
We have shown that mouse p-TGCs selectively amplify genomic regions containing the prolactin, serpin, and cathepsin gene families, as well as the NK/CLEC complex. While endoreplication of the entire p-TGC genome would also increase the copy number of these genes, selective amplification could add an additional layer of regulation. We propose a model in which endoreplication provides sufficient copies of the numerous genes necessary for general p-TGC metabolics, while amplification would then fine-tune the copy number of the genes most critical for p-TGC function. Additional evidence that more copies of these genes relative to the rest of the genome are advantageous can be found in their genomic arrangement, in which all of these gene families have expanded via tandem duplication [8, [10] [11] [12] . We hypothesize that selective amplification provides a mechanism for quickly producing the large amount of prolactins, serpins, cathepsins, and CLEC ligands necessary for placental function and resulting healthy pregnancies. This is the first time that selective genomic amplification has been identified in mammals, but further studies will be needed to explore whether such amplifications exist in humans and what roles they play in pregnancy. 
